Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medidata Solutions Inc    MDSO

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Medidata Solutions Inc : Medidata Solutions Announces Two-for-One Stock Split

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2013 | 12:31pm CEST

Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors approved a two-for-one (2:1) split of the Company's common stock at a regularly scheduled board meeting on November 7, 2013. The stock split will be structured in the form of a stock dividend.

The record date for the stock split is December 2, 2013. Shareholders of record as of such date will receive one new share of common stock for each share that they own. The distribution of the new shares will be made on December 16, 2013, and trading on a split-adjusted basis is expected to begin on or about December 17, 2013.

Medidata had approximately 26.8 million shares of common stock outstanding as of November 7, 2013. The stock split will increase the common shares outstanding to approximately 53.6 million.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud TM brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Investors:
Medidata Solutions
Hulus Alpay, 212-419-1025
[email protected]
or
Media:
Medidata Solutions
Gail Janowitz, 212-918-1792
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIDATA SOLUTIONS INC
10/19 MEDIDATA : Selected for Inaugural Fortune Future 50 List
10/12 MEDIDATA : Schedules Third Quarter Earnings Conference Call for October 26, 2017
10/06 LIFE SCIENCE SOFTWARE MARKET SIZE : World Current and Future Trend 2022
10/05 MEDIDATA : Neurological-Focused Pharmaceutical Company, Lundbeck, Continues Use ..
10/02 MEDIDATA : Industry Leaders Gather at Medidata NEXT Global 2017 to Discuss How T..
09/27 MEDIDATA : Opens New, Larger London EMEA Headquarters
08/24 MEDIDATA : to Present at Citi 2017 Global Technology Conference
08/24 MEDIDATA : Julie Iskow Honored Among PharmaVOICE 100's Most Inspiring People
08/24 MEDIDATA : ’s Julie Iskow Honored Among PharmaVOICE 100’s Most Inspi..
08/17 MEDIDATA : Fosun Pharma Selects Medidata's Unified Platform for Clinical Develop..
More news
News from SeekingAlpha
09/11 How To Profitably Build Your Cloud Portfolio
07/30 iShares Brings You Small Cap By The Thousands
07/18 Medidata Solutions' (MDSO) CEO Tarek Sherif on Q2 2017 Results - Earnings Cal..
07/18 Veeva Systems sues Medidata, others over employee rights
07/18 Medidata Solutions beats by $0.03, beats on revenue
Financials ($)
Sales 2017 554 M
EBIT 2017 123 M
Net income 2017 37,0 M
Finance 2017 15,3 M
Yield 2017 -
P/E ratio 2017 129,58
P/E ratio 2018 101,72
EV / Sales 2017 8,54x
EV / Sales 2018 7,06x
Capitalization 4 744 M
Chart MEDIDATA SOLUTIONS INC
Duration : Period :
Medidata Solutions Inc Technical Analysis Chart | MDSO | US58471A1051 | 4-Traders
Technical analysis trends MEDIDATA SOLUTIONS INC
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 85,5 $
Spread / Average Target 5,5%
EPS Revisions
Managers
NameTitle
Tarek A. Sherif Chairman & Chief Executive Officer
Glen Michael de Vries President & Director
Michael L. Capone Chief Operating Officer
Rouven Bergmann Chief Financial & Accounting Officer
Julie Iskow Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
MEDIDATA SOLUTIONS INC62.51%4 744
INTERNATIONAL BUSINESS MACHINES CORPORATION-3.07%151 040
ACCENTURE17.32%89 938
TATA CONSULTANCY SERVICES LIMITED9.64%76 055
AUTOMATIC DATA PROCESSING10.85%51 516
VMWARE, INC.49.12%48 395